Annual report pursuant to Section 13 and 15(d)

Revenue Recognition - Schedule of Revenue by Service Line (Details)

v3.22.4
Revenue Recognition - Schedule of Revenue by Service Line (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Disaggregation of Revenue [Line Items]    
Total revenue $ 20,551 $ 16,299
Functional Neurosurgery Navigation and Therapy - Disposable Products    
Disaggregation of Revenue [Line Items]    
Total revenue 7,587 7,696
Functional Neurosurgery Navigation and Therapy - Services    
Disaggregation of Revenue [Line Items]    
Total revenue 1,537 375
Subtotal - Functional Neurosurgery Navigation and Therapy    
Disaggregation of Revenue [Line Items]    
Total revenue 9,124 8,071
Biologics and Drug Delivery - Disposable Products    
Disaggregation of Revenue [Line Items]    
Total revenue 3,690 3,353
Biologics And Drug Delivery - Services And License Fees    
Disaggregation of Revenue [Line Items]    
Total revenue 5,430 3,442
Subtotal - Biologics and Drug Delivery    
Disaggregation of Revenue [Line Items]    
Total revenue 9,120 6,795
Capital Equipment and Software - Systems and Software Products    
Disaggregation of Revenue [Line Items]    
Total revenue 1,512 864
Capital Equipment and Software - Services    
Disaggregation of Revenue [Line Items]    
Total revenue 795 569
Subtotal - Capital Equipment and Software Revenue    
Disaggregation of Revenue [Line Items]    
Total revenue $ 2,307 $ 1,433